GeneNews to Present at the Bloom Burton & Co. Healthcare Investor Conference

TORONTO, May 21, 2013 (GLOBE NEWSWIRE) -- GeneNews Limited (TSX:GEN) ("GeneNews") announced today that its President and Chief Operating Officer, Gailina J. Liew, will present an update on the Company's business at the 2nd Annual Bloom Burton & Co. Healthcare Investor Conference on Wednesday, May 22, 2013 at 2:30 PM ET. The conference will be held at the Toronto Board of Trade in Toronto, ON.

About the Bloom Burton & Co. Healthcare Investor Conference

The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and international investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.

About GeneNews

GeneNews is a molecular diagnostics company focused on developing and commercializing proprietary blood-based diagnostic tests through the application of functional genomics to enable early diagnosis and personalized health management. The Company has developed a patented core platform technology, the Sentinel Principle^®, which has the power to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews has applied the Sentinel Principle^® in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews' lead product, ColonSentry^®, is the world's first blood test to assess an individual's current risk for colorectal cancer. For more information on GeneNews and ColonSentry^®, go to www.GeneNews.com or www.ColonSentry.com.

Forward-Looking Statements

This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.

CONTACT: Company Contact:
         Gailina Liew
         President & COO
         Office: (905) 739-2036
         Mobile: (416) 844-0649
         gliew@genenews.com
         
         Investor & Media Contact:
         Stephen Kilmer
         Kilmer Lucas Inc.
         Office: (212) 618-6347
         Mobile: (647) 872-4849
         stephen@kilmerlucas.com